The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Furiex Pharmaceuticals, Inc. (“Furiex” or the “Company”) (NasdaqGS: FURX) and other violations of state law by the board of directors of Furiex relating to the proposed buyout of the Company by Forest Laboratories, Inc. (“Forest”). Under the terms of the transaction, Furiex shareholders will receive $95.00 per share in cash for each share of Furiex stock they own. An additional $30.00 per share may be payable to shareholders in a Contingent Value Right (CVR) based on the status of eluxodoline, Furiex’s lead product, as a controlled drug following approval. The firm’s investigation seeks to determine, among other things, whether the Company’s board of directors breached their fiduciary duties by failing to maximize shareholder value before agreeing to enter into this transaction, and whether Forest is underpaying for Furiex shares. If you currently own common stock of Furiex and would like to learn more about the investigation being conducted by Brower Piven, without cost or obligation to you, click here: http://www.browerpiven.com/currentinvestigations.html. You may also request more information by contacting Brower Piven either by email at firstname.lastname@example.org or by telephone at (410) 415-6616. Attorneys at Brower Piven together have more than a century of experience litigating securities and other class action cases.
More from Press Releases
NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling
The Supreme Court rules that previous congressional action forbidding states from legalizing sports betting was unconstitutional.
Walmart CEO: 'We Are Transforming Globally' With Flipkart
On its investor call on Wednesday morning, Walmart discusses the Flipkart deal.
March 24 Full-Day Course Offering: Professional Approach to Trading SPX
OptionsProfits, the CBOE, and Option Pit are hosting a class on March 24 that covers a wide variety of methods to trade the S&P 500.